In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis

被引：0
|
作者：
Lens, Sabela [1 ]
机构：
[1] Univ Barcelona, Liver Unit Hosp Clin, Barcelona, Spain
来源：
GASTROENTEROLOGY | 2024年 / 167卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：623 / 624
页数：2
相关论文
共 50 条
  • [41] Towards establishing the standard of care for second-line therapy in advanced biliary tract cancer
    Beal, Eliza W.
    LANCET ONCOLOGY, 2021, 22 (11): : 1488 - 1490
  • [42] A retrospective study for the significance of second-line therapy for unresectable or recurrent biliary tract cancer
    Kawamoto, Yasuyuki
    Komatsu, Yoshito
    Yamamura, Takahiro
    Saito, Rika
    Ito, Ken
    Nakano, Shintaro
    Harada, Kazuaki
    Yuki, Satoshi
    Kuwatani, Masaki
    Sakamoto, Naoya
    ANNALS OF ONCOLOGY, 2021, 32 : S333 - S333
  • [43] Outcome of second-line chemotherapy for biliary tract cancer
    Bridgewater, John
    Palmer, Daniel
    Cunningham, David
    Iveson, Tim
    Gillmore, Roopinder
    Waters, Justin
    Harrison, Mark
    Wasan, Harpreet
    Corrie, Pippa
    Valle, Juan
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1511 - 1511
  • [44] Second-line therapies in advanced biliary tract cancers
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Borad, Mitesh J.
    Mahipal, Amit
    LANCET ONCOLOGY, 2020, 21 (01): : E29 - E41
  • [45] Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
    Jung, Jang Han
    Lee, Hee Seung
    Jo, Jung Hyun
    Cho, In Rae
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    Park, Jeong Youp
    CHEMOTHERAPY, 2017, 62 (06) : 361 - 366
  • [46] Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group
    D'Amato, D.
    O'Donnell, S. E.
    Cazzagon, N.
    Marconi, G.
    Gerussi, A.
    Cristoferi, L.
    Malinverno, F.
    Mancuso, C.
    Milani, C.
    Marzioni, M.
    Floreani, A.
    Invernizzi, P.
    Carbone, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E32 - E32
  • [47] Editorial: Unravelling real-world impact of second-line therapies in primary biliary cholangitis-Time to change our targets? Authors' reply
    Fernandez-Rodriguez, C. M.
    Gutierrez, M. L.
    Olveira, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (01) : 91 - 92
  • [48] Effective Alternative for Second-Line Therapy
    不详
    OBESITY FACTS, 2009, 2 (01) : 57 - 57
  • [49] Axitinim believe in Second-Line Therapy
    Roos, Frederik
    AKTUELLE UROLOGIE, 2012, 43 (03) : 135 - 137
  • [50] Second-line therapy for esophageal cancer
    Martin, Mike G.
    Govindan, Ramoswamy
    Morgensztern, Daniel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 871 - 876
12345